A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Conditions
Psoriasis · Overweight or Obesity
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Medical Dermatology Specialists, Phoenix, Arizona, United States
Contact: Principal Investigator (Lindsay Ackerman)First OC Dermatology Research Inc, Fountain Valley, California, United States
Contact: Principal Investigator (Vivian Laquer)Center For Dermatology Clinical Research, Inc., Fremont, California, United States
Contact: Principal Investigator (Sunil Dhawan)Metropolis Dermatology, Los Angeles, California, United States
Contact: Principal Investigator (Yen (James) Wang)Northridge Clinical Trials, Northridge, California, United States
Contact: Principal Investigator (Navid Ezra)Alliance for Multispecialty Research, LLC, Fort Myers, Florida, United States
Contact: Principal Investigator (Anais Badia)NeoClinical Research, Hialeah, Florida, United States
Contact: Principal Investigator (Martin Zaiac, MD)Skin Care Research, Hollywood, Florida, United States
Contact: Principal Investigator (Eduardo Weiss)Encore Medical Research, Hollywood, Florida, United States
Contact: Principal Investigator (Jerome Obed)MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research, Tampa, Florida, United States
Contact: Principal Investigator (Stephen Lockwood)TruDerm & TruSpa, Wellington, Florida, United States
Contact: Principal Investigator (Andleeb Usmani)Southeast Research Specialists, Douglasville, Georgia, United States
Contact: Principal Investigator (Firas George Hougeir)Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States
Contact: Principal Investigator (Scott Fretzin)The Indiana Clinical Trials Center, PC, Plainfield, Indiana, United States
Contact: Principal Investigator (Scott Guenthner)Equity Medical - Bowling Green, Bowling Green, Kentucky, United States
Contact: Principal Investigator (James Allred)Dermatology and Skin Cancer Specialists, LLC, Rockville, Maryland, United States
Contact: Principal Investigator (Benjamin Lockshin)Metro Boston Clinical Partners, Brighton, Massachusetts, United States
Contact: Principal Investigator (Mark Amster)David Fivenson, MD, PLC, Ann Arbor, Michigan, United States
Contact: Principal Investigator (David Fivenson)Great Lakes Research Group, Inc., Bay City, Michigan, United States
Contact: Principal Investigator (Brent Boyce)The Derm Institute of West Michigan, Caledonia, Michigan, United States
Contact: Principal Investigator (Kristi Hawley)Skin Cancer and Dermatology Institute - Reno, Reno, Nevada, United States
Contact: Principal Investigator (Michael Heaphy)Stracskin, Portsmouth, New Hampshire, United States
Contact: Principal Investigator (Abel Jarell)Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey, United States
Contact: Principal Investigator (Alexa Hetzel)Care Access - Hoboken, Hoboken, New Jersey, United States
Contact: Principal Investigator (Adolfo Fernandez- Obregon)Equity Medical, New York, New York, United States
Contact: Principal Investigator (Michael Cameron)Revival Research Institute, LLC, Cary, North Carolina, United States
Contact: Principal Investigator (Zain Husain)Onsite Clinical Solutions - Huntersville, Huntersville, North Carolina, United States
Contact: Principal Investigator (Nicole Seminara-Zambrzycka)Optima Research - Boardman, Boardman, Ohio, United States
Contact: Principal Investigator (Patrick Shannon)Oregon Dermatology and Research Center, Portland, Oregon, United States
Contact: Principal Investigator (Phoebe Rich, MD)Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, United States
Contact: Principal Investigator (Jonathan Wolfe)Columbia Dermatology & Aesthetics, Columbia, South Carolina, United States
Contact: Principal Investigator (Jessica Burgy)Alliance for Multispecialty Research, LLC, Myrtle Beach, South Carolina, United States
Contact: Principal Investigator (Brandon Coakley)DelRicht Research - Thompson's Station, Smyrna, Tennessee, United States
Contact: Principal Investigator (Pezhman Shoureshi)Bellaire Dermatology Associates, Bellaire, Texas, United States
Contact: Principal Investigator (Craig Teller)Modern Research Associates, PLLC, Dallas, Texas, United States
Contact: Principal Investigator (Jennifer Cather)Center for Clinical Studies, Houston, Texas, United States
Contact: Principal Investigator (Stephen Tyring)Austin Institute for Clinical Research, Pflugerville, Texas, United States
Contact: Principal Investigator (Edward Lain)Texas Dermatology and Laser Specialists, San Antonio, Texas, United States
Contact: Principal Investigator (John Browning)Center for Clinical Studies, Webster, Texas, United States
Contact: Principal Investigator (PATRICIA LEE)Tanner Clinic, Layton, Utah, United States
Contact: Principal Investigator (Scott Checketts)Bellevue Dermatology Clinic, Bellevue, Washington, United States
Contact: Principal Investigator (Clive Liu)Dermatology of Seattle, Burien, Washington, United States
Contact: Principal Investigator (Elie Levy)Office of Dr. Alma M. Cruz, Carolina, Puerto Rico
Contact: Principal Investigator (Alma M. Cruz-Santana)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company